Global Biomarkers Market to reach USD 129.14 million by 2027. Global Biomarkers Market is valued approximately at USD 51.81 Million in 2020 and is anticipated to grow with a healthy growth rate of more than 14% over the forecast period 2021-2027.The global Biomarkers market is being driven by increase in funding for biomarkers and rising prevalence of chronic diseases. Furthermore, new technological advancements and new launches, will provide new opportunities for the global Biomarkers industry. For instance, according to the World Population Prospects report of 2019, one in every six people across world will be over 65 years of age by year 2050, which may rise the incidences of chronic diseases. Also, in march 2021, a non-diagnostic screening device based on novel biomarker was approved by US FDA called as Tiger Tech Covid plus monitor . However, lack of reimbursement policies for biomarkers treatment, may impede market growth over the forecast period of 2021-2027.
Asia Pacific, North America, Europe, Latin America, and Rest of the World are the key regions considered for the regional analysis of global biomarkers. Rise in consumer awareness, proactive government action and technological advancement in healthcare infrastructure. makes North America the leading region across the world in terms of market share. Whereas Europe is also anticipated to exhibit the highest growth rate over the forecast period 2021-2027, due to presence of key market players and establishment of research institutes .
Major market player included in this report are:
F. Hoffmann-la roche ltd
Abbott laboratories
Epigenomics ag
General electric
Johnson & Johnson services, inc.
Thermo fisher scientific, Inc.
Bio-rad laboratories, inc.
Siemens healthineers ag
Qiagen
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Safety
Efficacy
Validation
By Disease:
Cancer
Cardiovascular Diseases
Neurological Diseases
Immunological Diseases
Others
By Application:
Diagnostics
Drug Discovery and Development
Personalized Medicine
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019
Base year - 2020
Forecast period - 2021 to 2027.
Target Audience of the Global Biomarkers Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
